Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
Titel:
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
Auteur:
Vesikari, Timo Langley, Joanne M Segall, Nathan Ward, Brian J Cooper, Curtis Poliquin, Guillaume Smith, Bruce Gantt, Soren McElhaney, Janet E Dionne, Marc van Damme, Pierre Leroux-Roels, Isabel Leroux-Roels, Geert Machluf, Nathalie Spaans, Johanna N Yassin-Rajkumar, Bebi Anderson, David E Popovic, Vlad Diaz-Mitoma, Francisco